← Back to NASA Technology Projects

Testing Mechanical Countermeasures for Cephalad Fluid Shifts

Completed TRL 6 (started at 4, targeting 6)

Description

Current evidence suggests that NASA's spaceflight-associated neuro-opthalmological syndrome (SANS/VIIP) risk is related to an elevation in intracranial pressure (ICP) during spaceflight, either consequent to or aggravated by cephalad fluid shifts in microgravity. From recent data, SANS occurs in >50% of astronauts, to varying degrees, and can lead to long term visual changes. Although its cause is unknown, its importance is high enough to motivate studies of potential countermeasures. The key objectives of this project were therefore: (1) to test and help validate two commercial devices as mechanical countermeasures for cephalad fluid shifts to potentially treat elevated ICP, (2) identify any potential adverse consequences during use or following release of such countermeasures, and (3) optimize deployment procedures for such countermeasures.

The Russians currently use Braslet—an elastic thigh band—to help sequester blood in the legs and alleviate symptoms resulting from cephalad fluid shifts. While promising, this device has not been tested as a SANS countermeasure. Lower body negative pressure (LBNP) is an alternative approach, which draws fluid into the legs using vacuum mechanism. Both have drawbacks, however. Braslet devices are custom-built, difficult to obtain, and have limited calibration options. LBNP is typically bulky and hence could only be used at limited times. As an alternative to Braslet, we tested the Kaatsu thigh cuff system. This commercially available system is designed for enhanced muscle training on Earth. In addition, we investigated use of a LymphaPress compression garment configured to provide a vascular resistance for fluid return from the lower body (as opposed to enhanced fluid return for which the device was designed for clinically). In Experiments 1 and 2 we conducted tests using both countermeasures (at different inflation pressures) in healthy subjects undergoing -6 degrees head-down tilt (HDT). We characterized cerebral blood volume and flow, intraocular pressure, structural eye parameters, and cerebral vascular parameter changes associated with application, maintenance, and following release of each countermeasure. In Experiment 3, we tested the Kaatsu system in neurointensive care unit patients with invasive ICP devices implanted to monitor and treat elevated ICP.

Together, the data from these studies suggested that—at the chosen inflation pressures--neither countermeasure exhibited significant potential as a treatment for, or mitigator of, cephalad fluid shifts and elevated ICP.

Benefits

Impact: This project provided the first tests of commercial, user-friendly and safety-tested devices as countermeasures potentially suitable for SANS.

Results include: (1) an assessment of both thigh cuffs and a compression garment as a SANS countermeasure, (2) assessment of the influence of these devices on cerebrovascular and ocular parameters, (3) parameterization of countermeasure deployment and rebound effects on multiple physiological variables, and (4) information regarding optimized deployment of the countermeasures.

Earth Benefits: Currently, there are few treatment methods for elevated ICP, which affects patients with traumatic brain injury, stroke, hydrocephalus, and cancer patients. None of the current methods involve non-invasive mechanical devices—instead focusing on surgical procedures or medications. This work therefore has the potential to identify one or more countermeasures and/or protocols—within a novel class of countermeasures—that could be used to help manage intracranial fluids and pressure. Since these approaches do not require drugs, they avoid the potential side effects, drug-drug interactions, or longer-lasting effects that often come from medication use.

Details

Technology areaHuman Health, Life Support, and Habitation Systems > Human Health and Performance > Prevention and Countermeasures
ProgramHuman Research Program (HRP)
Lead organizationNational Space Biomedical Research Institute, Houston, TX
Start date2015-06-01
End date2017-05-31

Project contacts

Listed on TechPort itself — the most direct way to ask about this specific project.

How to get involved

This is early/mid-stage (TRL 6) — the most realistic path in is NASA SBIR/STTR, which funds small businesses and research institutions to develop technology aligned with NASA's needs (equity-free, phased funding). Check whether a current SBIR/STTR solicitation topic overlaps with this project's technology area, or contact the project directly (above) to ask.

None of these are guaranteed paths for this specific project — TechPort itself doesn't have an "apply" button. Reaching out to the contact(s) above with a specific question is usually the fastest way to find out what's actually open.